Cite This Page
Bibliographic details for Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items
- Page name: Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items
- Author: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors
- Publisher: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, .
- Date of last revision: 30 January 2024 10:44 UTC
- Date retrieved: 6 May 2024 09:25 UTC
- Permanent URL: https://news.npo.digital/index.php?title=Review_associated_with_Access_Clinical_Assessment_as_well_as_Us_all_Fda_standards_Writeup_on_Biosimilar_Biologics_Items&oldid=627778
- Page Version ID: 627778
Citation styles for Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items
APA style
Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items. (2024, January 30). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 09:25, May 6, 2024 from https://news.npo.digital/index.php?title=Review_associated_with_Access_Clinical_Assessment_as_well_as_Us_all_Fda_standards_Writeup_on_Biosimilar_Biologics_Items&oldid=627778.
MLA style
"Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 30 Jan 2024, 10:44 UTC. 6 May 2024, 09:25 <https://news.npo.digital/index.php?title=Review_associated_with_Access_Clinical_Assessment_as_well_as_Us_all_Fda_standards_Writeup_on_Biosimilar_Biologics_Items&oldid=627778>.
MHRA style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 30 January 2024, 10:44 UTC, <https://news.npo.digital/index.php?title=Review_associated_with_Access_Clinical_Assessment_as_well_as_Us_all_Fda_standards_Writeup_on_Biosimilar_Biologics_Items&oldid=627778> [accessed 6 May 2024]
Chicago style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Review_associated_with_Access_Clinical_Assessment_as_well_as_Us_all_Fda_standards_Writeup_on_Biosimilar_Biologics_Items&oldid=627778 (accessed May 6, 2024).
CBE/CSE style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 30, 10:44 UTC [cited 2024 May 6]. Available from: https://news.npo.digital/index.php?title=Review_associated_with_Access_Clinical_Assessment_as_well_as_Us_all_Fda_standards_Writeup_on_Biosimilar_Biologics_Items&oldid=627778.
Bluebook style
Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items, https://news.npo.digital/index.php?title=Review_associated_with_Access_Clinical_Assessment_as_well_as_Us_all_Fda_standards_Writeup_on_Biosimilar_Biologics_Items&oldid=627778 (last visited May 6, 2024).
BibTeX entry
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "https://news.npo.digital/index.php?title=Review_associated_with_Access_Clinical_Assessment_as_well_as_Us_all_Fda_standards_Writeup_on_Biosimilar_Biologics_Items&oldid=627778", note = "[Online; accessed 6-May-2024]" }
When using the LaTeX package url (\usepackage{url}
somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Review associated with Access Clinical Assessment as well as Us all Fda standards Writeup on Biosimilar Biologics Items --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "\url{https://news.npo.digital/index.php?title=Review_associated_with_Access_Clinical_Assessment_as_well_as_Us_all_Fda_standards_Writeup_on_Biosimilar_Biologics_Items&oldid=627778}", note = "[Online; accessed 6-May-2024]" }